Sinovac Biotech Ltd (SVA): Free Cash Flow
-$561.10M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$561.10M | n/m | 2026-06-05, From 2025-01-01 |
| 2024-12-31 | -$152.85M | n/m | 2026-06-05, From 2024-01-01 |
| 2023-12-31 | -$17.52M | n/m | 2026-06-05, From 2023-01-01 |
| 2022-12-31 | -$1.11B | n/m | 2026-04-30, From 2022-01-01 |
| 2021-12-31 | $14.73B | n/c | 2026-04-30, From 2021-01-01 |
| 2020-12-31 | $351.82M | n/m | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $28.45M | n/m | 2022-04-29, From 2019-01-01 |
| 2018-12-31 | $2.33M | -95.1% | 2021-04-22, From 2018-01-01 |
| 2017-12-31 | $47.84M | n/m | 2020-04-30, From 2017-01-01 |
| 2016-12-31 | -$26.56M | n/c | 2019-04-29, From 2016-01-01 |
| 2015-12-31 | -$1.09M | n/m | 2018-05-11, From 2015-01-01 |
| 2014-12-31 | -$21.04M | n/c | 2017-11-22, From 2014-01-01 |
| 2013-12-31 | $443.0K | n/a | 2016-04-25, From 2013-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$561.10M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$6.31M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$43.98M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $195.80M | +3.9% |
| MannKind Corp (MNKD) | 2025-12-31 | $13.69M | -58.3% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$158.89M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $172.79M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $28.84M | +101.3% |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$45.71M | n/m |
Compare SVA, ARQT, ARDX, INVA side by side · Screen every company in Pharmaceutical Preparations ↗